SCHEMBL4430426

SCHEMBL4430426

O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2snc3ccccc23)CC1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 6/20 0.64
ALDH1A1 P00352 2/20 0.60
DRD2 P14416 2/20 0.60
HTR2A P28223 2/20 0.60
HTR2C P28335 2/20 0.60
ADRA1A P35348 2/20 0.60
HRH1 P35367 2/20 0.60
KCNH2 Q12809 2/20 0.60
SLC22A2 O15244 1/20 0.60
ABCB11 O95342 1/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
ADRA2C P18825 1/20 0.60
CNR1 P21554 1/20 0.60
ADRA1D P25100 1/20 0.60
HTR7 P34969 1/20 0.60
ADRA1B P35368 1/20 0.60
DRD3 P35462 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9287779 0.99 HTR1A (0.63) HTR1AALDH1A1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL11078746 0.98 HTR1A (0.62) HTR1AALDH1A1DRD2HTR2AHTR2C
Hydrochloric Acid SCHEMBL11078726 0.98 HTR1A (0.62) HTR1AALDH1A1DRD2HTR2AHTR2C
Tiospirone SCHEMBL78696 0.82
Tiospirone SCHEMBL29356145 0.82
SCHEMBL13532488 0.82
Tiospirone SCHEMBL122406 0.82
Tiospirone SCHEMBL11081111 0.81
SCHEMBL10469615 0.79 HTR1A (0.61) HTR1AALDH1A1DRD2HTR2AHTR2C
SCHEMBL9376454 0.78 HTR1A (0.52) HTR1ADRD2HTR2AHTR7DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4411901-A ANTIPSYCHOTICS MEAD JOHNSON & COMPANY (US) 1983-10-25 US claimed
EP-2083811-A1 METHODS OF TREATING MENTAL RETARDATION, DOWN'S SYNDROME, FRAGILE X SYNDROME AND AUTISM Seaside Therapeutics, LLC (US) 2009-08-05 EP disclosed
WO-2008066750-A1 METHODS OF TREATING MENTAL RETARDATION, DOWN'S SYNDROME, FRAGILE X SYNDROME AND AUTISM SEASIDE THERAPEUTICS, LLC (US) 2008-06-05 WO disclosed
US-4452799-A NEUROLEPTIC AGENTS MEAD JOHNSON & COMPANY (US) 1984-06-05 US disclosed
US-4411901-A ANTIPSYCHOTICS MEAD JOHNSON & COMPANY (US) 1983-10-25 US disclosed